BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25686091)

  • 1. Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.
    Aldabe R; Suárez-Amarán L; Usai C; González-Aseguinolaza G
    Pathogens; 2015 Feb; 4(1):46-65. PubMed ID: 25686091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis delta virus: Replication and pathogenesis.
    Sureau C; Negro F
    J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.
    Giersch K; Dandri M
    J Clin Transl Hepatol; 2015 Sep; 3(3):220-9. PubMed ID: 26623269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions between hepatitis B virus and delta virus.
    Shirvani-Dastgerdi E; Tacke F
    World J Virol; 2015 May; 4(2):36-41. PubMed ID: 25964870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and clinical significance of hepatitis D virus genotype II infection.
    Wu JC
    Curr Top Microbiol Immunol; 2006; 307():173-86. PubMed ID: 16903226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma.
    Puigvehí M; Moctezuma-Velázquez C; Villanueva A; Llovet JM
    JHEP Rep; 2019 Aug; 1(2):120-130. PubMed ID: 32039360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of HBV and HBV/HDV-Associated Liver Cirrhosis.
    Höner Zu Siederdissen C; Cornberg M
    Visc Med; 2016 Apr; 32(2):86-94. PubMed ID: 27413725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model.
    Ye X; Tateno C; Thi EP; Kakuni M; Snead NM; Ishida Y; Barnard TR; Sofia MJ; Shimada T; Lee ACH
    ACS Infect Dis; 2019 May; 5(5):738-749. PubMed ID: 30408957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis delta virus.
    Hughes SA; Wedemeyer H; Harrison PM
    Lancet; 2011 Jul; 378(9785):73-85. PubMed ID: 21511329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.
    Wu JC; Chen PJ; Kuo MY; Lee SD; Chen DS; Ting LP
    J Virol; 1991 Mar; 65(3):1099-104. PubMed ID: 1847439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis delta virus (HDV) infection.
    Gerken G; Meyer zum Büschenfelde KH
    Hepatogastroenterology; 1991 Feb; 38(1):29-32. PubMed ID: 2026385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis delta: immunopathogenesis and clinical challenges.
    Grabowski J; Wedemeyer H
    Dig Dis; 2010; 28(1):133-8. PubMed ID: 20460901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.
    Gomes-Gouvêa MS; Pereira Soares Mdo C; Guedes de Carvalho Mello IM; Brito EM; Pereira Moia Lde J; Bensabath G; Nunes HM; Carrilho FJ; Pinho JR
    Acta Trop; 2008 Jun; 106(3):149-55. PubMed ID: 18420172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.